Skip to navigation menu Skip to content
Informational Alert
Immunologic Disorders

Hyper IgM Syndrome, X-linked (XHIM) – CD40L Deficiency

Key Clinical and Laboratory Features

  • Common clinical features: Recurrent bacterial sinopulmonary infections, Pneumocytis jiroveci pneumonia (particularly in patients under age 5), chronic diarrhea (cryptosporidium is common and may lead to sclerosing cholangitis, liver cirrhosis and neuroendocrine malignancies in the abdomen), neutropenia
  • Other clinical features: Autoimmunity including cytopenias, hypoparathyroidism, nephritis, and rheumatoid arthritis. Anemia due to chronic parvovirus B19 infection.
  • Physical exam: Tonsils and lymph nodes are typically present. Lymphadenopathy and hepatosplenomegaly are common.
  • Common laboratory features: No expression/function of CD40 ligand. Normal T-cell counts and B-cell counts. IgM levels are typically elevated but may be normal while IgG and IgA levels are very low.

Testing Approach

GENE CD40L Gene Sequencing   The gold standard for confirming a diagnosis of CD40 ligand (CD40L) deficiency in a patient with suggestive symptoms and abnormal CD40 ligand protein flow.
PROTEIN AND FUNCTION CD40 Ligand Protein by Flow   This is both a protein test and a functional test that uses two different monoclonal antibodies to determine whether CD40 ligand protein is expressed on the surface of activated T cells. It also utilizes a CD40-Ig fusion protein to determine if the expressed CD40 ligand protein is able to functionally bind to CD40. Because this test evaluates both CD40L protein and its function, it is able to identify at least 99% of patients with XHIM.
  • Immunoglobulin levels: IgM typically elevated but may be normal while IgG and IgA are low.
  • Complete blood count with differential: neutropenia is common, particularly when patients are sick.
  • Lymphocyte subset analysis: T-cell counts are typically normal and B cells are present.
  • Chest X-ray to evaluate for pneumonia (Pneumocystis jirovecii in young patients).
  • Stool cultures to identify cryptosporidium in patients with diarrhea or abdominal complaints.

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies